These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1450467)

  • 21. Time dependence of solute removal during a single exchange.
    Wang T; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Adv Perit Dial; 1997; 13():23-8. PubMed ID: 9360645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of increasing exchange volume and frequency on peritoneal dialysis adequacy.
    Gao H; Lew SQ; Bosch JP
    Clin Nephrol; 1998 Dec; 50(6):375-80. PubMed ID: 9877111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of increasing exchange volume or frequency on CAPD efficiency.
    Johnston JR; Bernardini J; Holley J; Piraino B
    Adv Perit Dial; 1995; 11():97-100. PubMed ID: 8534748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transperitoneal solute movement in children.
    Gruskin AB; Rosenblum H; Baluarte HJ; Morgenstern BZ; Polinsky MS; Perlman SA
    Kidney Int Suppl; 1983 Nov; 15():S95-100. PubMed ID: 6584681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D
    Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight limitations for weekly urea clearances using various exchange volumes in continuous ambulatory peritoneal dialysis.
    Nolph KD; Jensen RA; Khanna R; Twardowski ZJ
    Perit Dial Int; 1994; 14(3):261-4. PubMed ID: 7948239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining peritoneal dialysis adequacy: Kt/Vurea revisited.
    Zhe XW; Shan YS; Cheng L; Tian XK; Wang T
    Ren Fail; 2007; 29(3):347-52. PubMed ID: 17497450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodialysis together with peritoneal dialysis is one of the simplest ways to maintain adequacy in continuous ambulatory peritoneal dialysis.
    Kawanishi H; Moriishi M; Katsutani S; Sakikubo E; Tsuchiya S
    Adv Perit Dial; 1999; 15():127-31. PubMed ID: 10682087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics and dosing predictions for daily haemofiltration.
    Leypoldt JK; Jaber BL; Lysaght MJ; McCarthy JT; Moran J
    Nephrol Dial Transplant; 2003 Apr; 18(4):769-76. PubMed ID: 12637647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance of large exchange volumes by peritoneal dialysis patients.
    Sarkar S; Bernardini J; Fried L; Johnston JR; Piraino B
    Am J Kidney Dis; 1999 Jun; 33(6):1136-41. PubMed ID: 10352203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Kidney Int; 2003 Dec; 64(6):2238-43. PubMed ID: 14633148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urea and uremic solutes: how does peritoneal dialysis work?
    Bammens B
    Semin Nephrol; 2011 Mar; 31(2):127-37. PubMed ID: 21439427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adequacy of continuous ambulatory peritoneal dialysis.
    Tzamaloukas AH; Murata GH
    Int J Artif Organs; 1993 Aug; 16(8):567-72. PubMed ID: 8225647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timely initiation of dialysis: a urea kinetic approach.
    Keshaviah PR; Emerson PF; Nolph KD
    Am J Kidney Dis; 1999 Feb; 33(2):344-8. PubMed ID: 10023648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of nitrogen removal mass in uremic patients on different modalities of dialysis therapy.
    Chen TW; Huang TP; Wang ML
    J Formos Med Assoc; 2000 Feb; 99(2):116-22. PubMed ID: 10770025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
    Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.